Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 463Neoplasms, Plasma Cell 81Lymphoma 75Leukemia 51Lymphoma, Non-Hodgkin 49Leukemia, Lymphocytic, Chronic, B-Cell 45Myelodysplastic Syndromes 43Immunoglobulin Light-chain Amyloidosis 42Leukemia, Myeloid, Acute 39Hodgkin Disease 37Precursor Cell Lymphoblastic Leukemia-Lymphoma 33Neoplasms 32Hematologic Neoplasms 31Breast Neoplasms 31Myeloproliferative Disorders 29Lymphoma, Large B-Cell, Diffuse 29Lymphoma, Follicular 29Monoclonal Gammopathy of Undetermined Significance 28Smoldering Multiple Myeloma 25Lymphoma, Mantle-Cell 25Lymphoma, B-Cell, Marginal Zone 24Recurrence 23Burkitt Lymphoma 21Amyloidosis 21Prostatic Neoplasms 20Lymphoma, T-Cell, Cutaneous 20Lymphoma, Large-Cell, Immunoblastic 19Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 19Waldenstrom Macroglobulinemia 18Sezary Syndrome 18

Interventions

Surveys and Questionnaires 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Behavioral Symptoms × Plasma cell × Clear all
NCT04388735 2020-05-14

Multiple Myeloma (MM) Quality of Life (QOL) Study

Massachusetts General Hospital

Unknown
360 enrolled
Plasma cell

Behavioral Symptoms, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡